Submit an application for a medical grant or sponsorship
We accept submission requests for:
Medical Educational Requests
Support for independent accredited or unaccredited medical education activities or education directed to healthcare professionals, healthcare organizations, patient organizations, patients, or other members of the healthcare community.
Patient Advocacy Organization – Charitable Contributions
Financial or in-kind contributions to patient advocacy groups and organizations with not-for-profit status, where the primary purpose of the contribution is charitable or philanthropic to support the general mission/activities of organizations. Contributions are intended solely for charitable purposes, which means BioCryst receives nothing of value in return other than the customary acknowledgment of support. Unlike for sponsorship requests, BioCryst does not expect to receive any benefit, consideration, or service in return for charitable contributions to patient advocacy organizations.
Sponsorships Requests
Funding to an eligible entity, including patient advocacy organizations for events or activities, in exchange for tangible benefits from the funding recipient, such as the opportunity for BioCryst advertisements at an event or activity, exhibit space at an event, admission to certain events, etc.
Charitable Contributions
Donations are tax-deductible contributions to support 501(c)(3) and 501(c)(6) nonprofit organizations. The current areas of focus for BioCryst are to promote health-related programs outside of BioCryst therapeutic areas for 501(c)(3) organizations, certain charitable events in support of community health and health education, wellness, scholarships or supporting the education of pharmacy students, and to support programmatic activities and scholarships of 501(c)(3) organizations, including hospital foundations.
BioCryst invites you to submit an application. When submitting a request, you will be guided through the electronic submission process with instructions and help options.
Areas of interest
Medical – Hereditary Angioedema (HAE):
Defining overall disease burden for patients, families and others impacted by HAE/ bradykinin-mediated angioedema
- Understanding the impact of HAE disease and unmet needs of underrepresented patient populations
- Understanding HAE disease and treatment burden on quality of life (including physical and mental health impacts) on patients and caregivers
- Healthcare utilization costs and financial burden of HAE
- Evolution of understanding and classification of bradykinin-mediated angioedemas (i.e., HAE normal C1-INH, hereditary, acquired, contact pathway mutations)
Redefining HAE/bradykinin-mediated angioedema disease management goals and optimal outcomes
- Diagnosis, management, and outcome measures of success for patients living with HAE/bradykinin-mediated angioedema
- Review of treatment guidelines/recommendations
- Individualized support and shared decision making to improve patient experience and long-term goals for success
- Options on switching from previous prophylaxis, on-demand treatment, and patient-specific considerations for approved therapies (individualized approach)
- Diagnosis and management of pediatric patients with HAE/bradykinin-mediated angioedema
Patient Advocacy:
Local, regional, and global patient advocacy focused on:
- Hereditary Angioedema (HAE)
- Diabetic Macular Edema (DME) and vision loss
- Netherton Syndrome
- Broader rare disease community